A propensity score‐matched comparison of biodegradable polymer vs second‐generation durable polymer drug‐eluting stents in a real‐world population

Abstract

Efficacy and safety of BP-DES were not better than DP-DES at one-year follow-up.

Cost‐effectiveness analysis of biodegradable polymer versus durable polymer drug‐eluting stents incorporating real‐world evidence

“…Patients were predominantly males (82%), 57% had acute MI, and 77% had complex lesions as defined by B2/C American College of Cardiology/American Heart Association (ACC/AHA) lesion class . The baseline characteristics of the patients which have been published elsewhere are provided in Table . Cox regression analysis was performed to estimate the relative risk of events that was expressed as hazard ratio.…”